GAIL ECKHARDT to Maximum Tolerated Dose
This is a "connection" page, showing publications GAIL ECKHARDT has written about Maximum Tolerated Dose.
Connection Strength
0.062
-
A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumors. Ann Oncol. 2018 07 01; 29(7):1561-1568.
Score: 0.038
-
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial. Lancet Oncol. 2012 Aug; 13(8):773-81.
Score: 0.025